Abstract
Immunizations are a critical feature of preventative care for term and preterm newborns. All infants, regardless of gestational age, should receive hepatitis B vaccine shortly after delivery. For preterm infants who remain in the neonatal intensive care unit, providers may be tasked with administering their 2-, 4-, 6-, or even 12-month vaccines. Ensuring that these immunizations are given promptly will prevent under-immunization at the time of nursery discharge. In addition, preterm infants may be eligible for one or both of influenza vaccination or palivizumab administration depending on risk factors and the time of year. The appropriate timing and indications for these immunizations for term and preterm infants are described in this chapter.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhao Z, Murphy TV. Which newborns missed the hepatitis B birth dose vaccination among U.S. children? Prev Med. 2013;57:613–7.
Meleth S, Dahlgren LS, Sankaran R, Sankaran K. Vaccination of infants discharged from a neonatal intensive care unit. CMAJ. 1995;153:415–9.
Navar-Boggan AM, Halsey NA, Escobar GJ, Golden WC, Klein NP. Underimmunization at discharge from the neonatal intensive care unit. J Perinatol. 2012;32:363–7.
Ko SC, Fan L, Smith EA, et al. Estimated annual perinatal hepatitis B virus infections in the United States, 2000-2009. J Pediatric Infect Dis Soc. 2016;5:114–21.
Stevens CE, Toy P, Kamili S, et al. Eradicating hepatitis B virus: the critical role of preventing perinatal transmission. Biologicals. 2017;50:3–19.
Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006;332:328–36.
Schillie S, Murphy TV, Fenlon N, Ko S, Ward JW. Update: shortened interval for postvaccination serologic testing of infants born to hepatitis B-infected mothers. MMWR Morb Mortal Wkly Rep. 2015;64:1118–20.
Ben Jmaa W, Hernandez AI, Sutherland MR, et al. Cardiorespiratory events and inflammatory response after primary immunization in preterm infants <32 weeks gestational age: a randomized controlled study. Pediatr Infect Dis J. 2017;36:988–94.
Montague EC, Hilinski JA, Williams HO, et al. Respiratory decompensation and immunization of preterm infants. Pediatrics. 2016;137:e20154225.
DeMeo SD, Raman SR, Hornik CP, et al. Adverse events after routine immunization of extremely-low-birth-weight infants. JAMA Pediatr. 2015;169:740–5.
Maltezou HC, Ftika L, Theodoridou M. Nosocomial pertussis in neonatal units. J Hosp Infect. 2013;85:243–8.
Klein NP, Massolo ML, Greene J, et al. Risk factors for developing apnea after immunization in the neonatal intensive care unit. Pediatrics. 2008;121:463–9.
Yasmin S, Sunenshine R, Bisgard KM, et al. Healthcare-associated pertussis outbreak in Arizona: challenges and economic impact, 2011. J Pediatric Infect Dis Soc. 2014;3:81–4.
Robinson MJ, Heal C, Gardener E, Powell P, Sims DG. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease. Pediatrics. 2004;113:733–7.
Tsuda K, Iwasaki S, Horiguchi H, et al. Immune response to Haemophilus influenzae type b conjugate vaccine in preterm infants. Pediatr Int. 2012;54:64–7.
Wysocki J, Center KJ, Brzostek J, et al. A randomized study of fever prophylaxis and the immunogenicity of routine pediatric vaccinations. Vaccine. 2017;35:1926–35.
Sharma R, Hudak ML, Premachandra BR, et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J. 2002;21:1099–105.
Rotbart HA, Nelson WL, Glode MP, et al. Neonatal rotavirus-associated necrotizing enterocolitis: case control study and prospective surveillance during an outbreak. J Pediatr. 1988;112:87–93.
Jaques S, Bhojnagarwala B, Kennea N, Duffy D. Slow uptake of rotavirus vaccination in UK neonatal units. Arch Dis Child Fetal Neonatal Ed. 2014;99:F252.
Stumpf KA, Thompson T, Sanchez PJ. Rotavirus vaccination of very low birth weight infants at discharge from the NICU. Pediatrics. 2013;132:e662–5.
Newman RD, Grupp-Phelan J, Shay DK, Davis RL. Perinatal risk factors for infant hospitalization with viral gastroenteritis. Pediatrics. 1999;103:E3.
Anagnostropoulos D, Valioulis J, Sfougaris D, Maliaropoulos N, Spyridakis J. Morbidity and mortality of short bowel syndrome in infancy and childhood. Eur J Pediatr Surg. 1991;1:273–6.
Thrall S, Doll MK, Nhan C, et al. Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units. Vaccine. 2015;33:5095–102.
Monk HM, Motsney AJ, Wade KC. Safety of rotavirus vaccine in the NICU. Pediatrics. 2014;133:e1555–60.
Fang AY, Tingay DG. Early observations in the use of oral rotavirus vaccination in infants with functional short gut syndrome. J Paediatr Child Health. 2012;48(6):512.
Javid PJ, Sanchez SE, Jacob S, et al. The safety and immunogenicity of rotavirus vaccination in infants with intestinal failure. J Pediatric Infect Dis Soc. 2014;3:57–65.
Hiramatsu H, Suzuki R, Nagatani A, et al. Rotavirus vaccination can be performed without viral dissemination in the neonatal intensive care unit. J Infect Dis. 2018;217:589–96.
Rivera L, Pena LM, Stainier I, et al. Horizontal transmission of a human rotavirus vaccine strain – a randomized, placebo-controlled study in twins. Vaccine. 2011;29:9508–13.
Payne DC, Edwards KM, Bowen MD, et al. Sibling transmission of vaccine-derived rotavirus (RotaTeq) associated with rotavirus gastroenteritis. Pediatrics. 2010;125:e438–41.
Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: recommendations from the committee on immunization practices – United States, 2017-18 influenza season. MMWR Recomm Rep. 2017;66:1–20.
Tinnion RJ, Berrington JE. Flu vaccination for ex-preterms and infants under 6 months – are we getting it right? Arch Dis Child. 2010;95:400–1.
Madhi SA, Cutland CL, Kuwanda L, et al. Influenza vaccination of pregnant women and protection of their infants. N Engl J Med. 2014;371:918–31.
McLellan JS, Ray WC, Peeples ME. Structure and function of RSV surface glycoproteins. Curr Top Microbiol Immunol. 2013;372:83–104.
The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531–7.
Blanken MO, Rovers MM, Molenaar JM, et al. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med. 2013;368:1791–9.
Brady MT, Byington CL, Davies HD, et al. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics. 2014;134:415–20.
Geskey JM, Ceneviva GD, Brummel GL, Graff GR, Javier MC. Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit? Clin Ther. 2004;26:2130–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Ascher Bartlett, J.M. (2018). Immunizations in the Nursery. In: Cantey, J. (eds) Neonatal Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-90038-4_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-90038-4_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90037-7
Online ISBN: 978-3-319-90038-4
eBook Packages: MedicineMedicine (R0)